Previous Close | 0.0100 |
Open | 0.0100 |
Bid | 0.0100 x 0 |
Ask | 0.0190 x 0 |
Day's Range | 0.0100 - 0.0100 |
52 Week Range | 0.0005 - 0.0240 |
Volume | |
Avg. Volume | 0 |
Market Cap | N/A |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Vancouver, British Columbia--(Newsfile Corp. - June 14, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical") is providing an update with respect to the Management Cease Trade Order ("MCTO") issued by the British Columbia Securities Commission (the "BCSC") under National Policy 12-203 - Management Cease Trade Orders ("NP 12-203"), effective as of May 2, 2024, and as previously announced by the Company. The MCTO was issued by the ...
Vancouver, British Columbia--(Newsfile Corp. - June 6, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), announces that it, along with certain others, filed a Notice of Civil Claim (the "Claim") in the British Columbia Supreme Court on June 5, 2024 against its former legal counsel (the "Defendants"). The Claim alleges that the Defendants were negligent in the provision of legal advice in relation to the Company's issuance of ...
Vancouver, British Columbia--(Newsfile Corp. - May 29, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical") is pleased to announce that further to its news release dated May 16, 2024, the Company has closed the first tranche of its non-brokered private placement (the "Private Placement") for gross proceeds of $115,000 through the sale of 4,600,000 units of the Company ("Units") at a price of $0.025 per Unit.Each Unit ...